| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 6.08▲ | 6.11▼ | 6.15▼ | 6.86▼ | 6.81▼ |
| MA10 | 6.09▼ | 6.18▼ | 6.08▲ | 7.33▼ | 5.95▲ |
| MA20 | 6.17▼ | 6.10▼ | 6.27▼ | 7.09▼ | 5.02▲ |
| MA50 | 6.04▲ | 6.82▼ | 7.25▼ | 5.90▲ | 3.30▲ |
| MA100 | 6.26▼ | 7.40▼ | 7.37▼ | 4.95▲ | 2.87▲ |
| MA200 | 7.01▼ | 7.33▼ | 6.91▼ | 3.60▲ | 4.08▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.015▼ | 0.051▲ | 0.047▲ | -0.243▼ | 0.171▲ |
| RSI | 46.997▼ | 39.210▼ | 33.928▼ | 42.304▼ | 59.133▲ |
| STOCH | 19.165▼ | 37.341 | 62.389 | 32.465 | 75.722 |
| WILL %R | -79.310▼ | -48.592 | -49.306 | -88.436▼ | -53.762 |
| CCI | -51.100 | -11.780 | -22.197 | -133.400▼ | 65.290 |
|
Tuesday, March 17, 2026 09:18 AM
NervGen Pharma Corp. NVG-291 shows lasting gains in chronic spinal cord injury; Phase 3 and FDA fast paths ahead. Click for this NGEN update.
|
|
Thursday, March 12, 2026 05:45 AM
Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today announced that Remy ...
|
|
Wednesday, March 11, 2026 04:38 AM
Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today provided business ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 25/03/26 | 6.17 | 6.43 | 6.055 | 6.085 | 142,994 |
| 24/03/26 | 6.42 | 6.52 | 5.73 | 6.04 | 735,186 |
| 23/03/26 | 7.2654 | 8.0482 | 6.42 | 6.55 | 681,185 |
| 20/03/26 | 8.00 | 8.17 | 7.52 | 7.54 | 1,429,382 |
| 19/03/26 | 7.79 | 8.3828 | 7.71 | 8.07 | 638,025 |
| 18/03/26 | 7.92 | 8.11 | 7.63 | 7.78 | 512,971 |
| 17/03/26 | 7.74 | 8.25 | 7.74 | 7.85 | 331,878 |
| 16/03/26 | 7.75 | 8.80 | 7.67 | 7.84 | 377,654 |
| 13/03/26 | 7.60 | 8.03 | 7.555 | 7.83 | 243,610 |
| 12/03/26 | 7.27 | 7.79 | 7.055 | 7.69 | 261,879 |
|
|
||||
|
|
||||
|
|